We conducted this research to identify the roles of M2 macrophage-derived exosomal AGAP2-AS1 in the development of lung cancer, and we found that exosomal AGAP2-AS1 promoted radiotherapy immunity of lung cancer patients after radiotherapy by downregulating miR-296 and overexpressing NOTCH2. Here, AGAP2 is linked to lung carcinoma.